Mikael Dolsten

Entity type image
Type: Person
Name: Mikael Dolsten
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Pharmas RD Deals With Foundations May Negatively Impact Image

Dr. Mikael Dolsten, Pfizer's President of Worldwide Research, wrote a spirited response to my post. To be fair, Dr. Dolsten gave a number of reasons to justify this deal, including the need for breaking down silos that exist in pharmaceutical R&D, the ... [Published Birmingham Star - 11 hours ago]
First reported May 10 2013 - Updated May 10 2013 - 1 reports
Pfizer Inc
Pfizer Inc

Pfizer R&D webcast today

Pfizer Inc. is inviting investors and the public to attend a webcast at 11 a.m. today in which Mikael Dolsten, president of its research-and-development division worldwide, speaks during the Morgan Stanley 2013 R&D Seminar called Reigniting Pharma.To ... [Published TheDay.com - May 10 2013]
First reported Jan 11 2013 - Updated Jan 11 2013 - 1 reports
Telik Inc
Telik Inc

4 Healthcare Stock Stories for Investor Wellbeing

Johnson & Johnson ( NYSE:JNJ ): Closing price $72.35 On Thursday, an FDA advisory panel okayed J&J’s canagliflozin, a drug for diabetes that could be the first in a new class of domestic drugs to treat the disease, although several panel members ... [Published Wall St. Cheat Sheet - Jan 11 2013]
First reported Jan 11 2013 - Updated Jan 11 2013 - 1 reports
Verastem Inc
Verastem Inc

4 Healthcare Stock Stories for Investors to Take Daily

Pfizer ( NYSE:PFE ): Closing price $26.76 Pfizer might request an expedited review from the FDA for its treatment to slow a type of incurable breast cancer which is currently in Phase 2 trial, said Bloomberg, citing statements of Mikael Dolsten, head ... [Published Wall St. Cheat Sheet - Jan 11 2013]
First reported Jan 10 2013 - Updated Jan 10 2013 - 1 reports
Redbox
Redbox

Pfizer Hopes For Expedited Review and 3 Dow Movers Sparking Chatter

Wal-Mart Stores ( NYSE:WMT ): Current price $68.12 The Wal-Mart chief executive was aware of the bribery allegations in 2005, say e-mails, according to CNBC. Start 2013 better than ever by saving time and making money with your Limited Time ... [Published Wall St. Cheat Sheet - Jan 10 2013]

More Content

All (11) | News (2) | Reports (2) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Pharmas RD Deals With Foundations May Negativel... [Published Birmingham Star - 11 hours ago]
Pfizer R&D webcast today [Published TheDay.com - May 10 2013]
Pfizer Invites Public to View and Listen to Web... [Published Business Wire Communications News - May 08 2013]
Pfizer Invites Public to View and Listen to Web... [Published Business Wire Health News - May 08 2013]
Pfizer's CEO Discusses Q1 2013 Results - Earnin... [Published Seeking Alpha - Apr 30 2013]
Deals of the Week: An Update On A Potential Pfi... [Published The IN VIVO Blog - Mar 29 2013]
Pfizer's CEO Discusses Q4 2012 Results - Earnin... [Published Healthcare Sector and Stocks Analysis from Seek ... - Jan 30 2013]
Your Cheat Sheet to the Top Dow 30 Stock Storie... [Published Wall St. Cheat Sheet - Jan 12 2013]
4 Healthcare Stock Stories for Investor Wellbeing [Published Wall St. Cheat Sheet - Jan 11 2013]
4 Healthcare Stock Stories for Investors to Tak... [Published Wall St. Cheat Sheet - Jan 11 2013]
Pfizer Hopes For Expedited Review and 3 Dow Mov... [Published Wall St. Cheat Sheet - Jan 10 2013]
1
In Focus
  •  
Tim Anderson, Ian Read, Olivier Brandicourt, [more]
  •  
Pfizer Inc, New York Stock Exchange, Telik Inc, [more]
  •  
FDA Food & Drug Administration, European Union, European Commission, [more]
  •  
Research & Development, Health Care, Drugs, [more]
  •  
Xeljanz, ELIQUIS, Prevnar, [more]
  •  
Louisville (Colorado, United States), Palma de Mallorca, Rio Rancho (United States), [more]
  •  
United States, Australia, Japan, [more]
  •  
Diseases, Medication, Poverty, [more]
  •  
Pharma & Biotech
Wall St. Cheat Sheet, Birmingham Star, Healthcare Sector and Stocks Analysis from Seek..., [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Deals of the Week: An Update On A Potential Pfi... [Published The IN VIVO Blog - Mar 29 2013]
br /> Pfizer's Chairman and CEO Ian Read doesn’t make himself available for interviews readily, so a March 26th note from Sanford Bernstein’s esteemed pharma analyst Tim Anderson caught our attention pronto. The note describes a teleconference call ...
Your Cheat Sheet to the Top Dow 30 Stock Storie... [Published Wall St. Cheat Sheet - Jan 12 2013]
Here’s your Cheat Sheet to the week in Dow 30 business news: Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >> Chevron Corporation  ( NYSE:CVX ): Current price $109.43 ...
4 Healthcare Stock Stories for Investor Wellbeing [Published Wall St. Cheat Sheet - Jan 11 2013]
Johnson & Johnson ( NYSE:JNJ ): Closing price $72.35 On Thursday, an FDA advisory panel okayed J&J’s canagliflozin, a drug for diabetes that could be the first in a new class of domestic drugs to treat the disease, although several panel members ...
4 Healthcare Stock Stories for Investors to Tak... [Published Wall St. Cheat Sheet - Jan 11 2013]
Pfizer ( NYSE:PFE ): Closing price $26.76 Pfizer might request an expedited review from the FDA for its treatment to slow a type of incurable breast cancer which is currently in Phase 2 trial, said Bloomberg, citing statements of Mikael Dolsten, head ...
Pfizer Hopes For Expedited Review and 3 Dow Mov... [Published Wall St. Cheat Sheet - Jan 10 2013]
Wal-Mart Stores ( NYSE:WMT ): Current price $68.12 The Wal-Mart chief executive was aware of the bribery allegations in 2005, say e-mails, according to CNBC. Start 2013 better than ever by saving time and making money with your Limited Time ...
1

Press Releases

sort by: Date | Relevance
Pfizer Invites Public to View and Listen to Web... [Published Business Wire Communications News - May 08 2013]
Pfizer Invites Public to View and Listen to Web... [Published Business Wire Health News - May 08 2013]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.